HoloMonitor Fluorescence Now at Novo Nordisk

Phase Holographic Imaging (PHI) recently installed a fluorescence-equipped HoloMonitor® system at Novo Nordisk A/S. The installation is part of a series of test installations to allow experienced HoloMonitor customers to provide feedback regarding functionality and user-friendliness prior to the upcoming product launch.

Fluorescence microscopy is an essential tool used by cell biologists to study the genetic activity of cells. However, fluorescence microscopy is harmful to the cells, making it difficult to study genetic activity over time. PHI solves this dilemma by combining holography with fluorescence microscopy.

“HoloMonitor is perfectly suited for our cell cultures in flow applications as well as many other types of experiments where tracking cell behavior and motility in real-time is a must. To study cell samples in the incubator using fluorescence is a necessary next step for our research.”

― Markus Bosteen, Senior Scientist at Novo Nordisk, Copenhagen (right)

For additional information, please contact:
Peter Egelberg
E-mail: ir@phiab.se
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.